β-Amyloid, Tau, Neurodegeneration Classification and Eligibility for Anti-amyloid Treatment in a Memory Clinic Population.
Anna RosenbergUlf Öhlund-WistbackaAnette HallAlexandre BonnardGöran HagmanMarie RydénCharlotta ThunborgFleur WiggenraadAnna Sandebring-MattonAlina SolomonMiia KivipeltoPublished in: Neurology (2022)
In a memory clinic setting with all necessary infrastructure and national guidelines in place for dementia diagnostic examination (best-case scenario), most of the patients did not meet the eligibility criteria for anti-amyloid treatment. Continuing the development of disease-modifying treatments with different mechanisms of action is a priority.